Originally posted 2013-02-20 14:00:10. Republished by Blog Post Promoter
Hello? Walter Olson:
The patenting of software, in contrast to the patenting of chemical and pharmaceutical compounds, generates relatively high litigation costs and low benefits . . .
What’s with the low benefits? It says relatively high litigation costs! What’s not to love?
Oh. You mean low benefits for companies, shareholders, innovators and consumers? Them?
Oh, oh. Never mind.